Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss

Bence György,Carl Nist-Lund,Bifeng Pan,Yukako Asai,K. Domenica Karavitaki,Benjamin P. Kleinstiver,Sara P. Garcia,Mikołaj P. Zaborowski,Paola Solanes,Sofia Spataro,Bernard L. Schneider,J. Keith Joung,Gwenaëlle S. G. Géléoc,Jeffrey R. Holt,David P. Corey
DOI: https://doi.org/10.1038/s41591-019-0500-9
IF: 82.9
2019-07-01
Nature Medicine
Abstract:Since most dominant human mutations are single nucleotide substitutions<sup><a href="/articles/s41591-019-0500-9#ref-CR1">1</a>,<a href="/articles/s41591-019-0500-9#ref-CR2">2</a></sup>, we explored gene editing strategies to disrupt dominant mutations efficiently and selectively without affecting wild-type alleles. However, single nucleotide discrimination can be difficult to achieve<sup><a href="/articles/s41591-019-0500-9#ref-CR3">3</a></sup> because commonly used endonucleases, such as <i>Streptococcus pyogenes</i> Cas9 (SpCas9), can tolerate up to seven mismatches between guide RNA (gRNA) and target DNA. Furthermore, the protospacer-adjacent motif (PAM) in some Cas9 enzymes can tolerate mismatches with the target DNA<sup><a href="/articles/s41591-019-0500-9#ref-CR3">3</a>,<a href="/articles/s41591-019-0500-9#ref-CR4">4</a></sup>. To circumvent these limitations, we screened 14 Cas9/gRNA combinations for specific and efficient disruption of a nucleotide substitution that causes the dominant progressive hearing loss, DFNA36. As a model for DFNA36, we used <i>Beethoven</i> mice<sup><a href="/articles/s41591-019-0500-9#ref-CR5">5</a></sup>, which harbor a point mutation in <i>Tmc1</i>, a gene required for hearing that encodes a pore-forming subunit of mechanosensory transduction channels in inner-ear hair cells<sup><a href="/articles/s41591-019-0500-9#ref-CR6">6</a></sup>. We identified a PAM variant of <i>Staphylococcus aureus</i> Cas9 (SaCas9-KKH) that selectively and efficiently disrupted the mutant allele, but not the wild-type <i>Tmc1/TMC1</i> allele, in <i>Beethoven</i> mice and in a DFNA36 human cell line. Adeno-associated virus (AAV)-mediated SaCas9-KKH delivery prevented deafness in <i>Beethoven</i> mice up to one year post injection. Analysis of current ClinVar entries revealed that ~21% of dominant human mutations could be targeted using a similar approach.
biochemistry & molecular biology,cell biology,medicine, research & experimental
What problem does this paper attempt to address?